Bristol-Myers Squibb to pay US150m settlement

摘要

Bristol-Myers Squibb has agreed to pay US150m in a settlement with the US Securities and Exchange Commission after an investigation uncovered illegal accounting practices at the US drugs company.The sum is made up of a fine of US100m along with a payment to a shareholders' fund of US50m.The penalty is one of the biggest ever payouts by a US company to the SEC.This announcement follows BMS's recent payment of US300m to settle a class-action lawsuit taken by a number of its shareholders.